Wfm, Cost, Vrx, Kr & Extra

Valeant Pharmaceuticals — The company announced activist investor John Paulson will join the board of directors.
” Morgan Stanley also slashed its price target on the stock to $23 from $32.
Barclays also raised its price target to $48 from $38.
“Stryker —The medical technology firm is acquiring Novadaq Technologies, a fluorescence-imaging company, for $11.75 a share, or about $701 million.
“Whole Foods —The grocery store chain’s stock was upgraded to overweight from equal weight at Barclays.

Read more on: http://www.cnbc.com/bob-pisani